Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens

Verfasser / Beitragende:
[C. Klinguer, A. Beck, P. De-Lys, M. C. Bussat, A. Blaecke, F. Derouet, J. Y. Bonnefoy, T. N. Nguyen, N. Corvaia, D. Velin]
Ort, Verlag, Jahr:
2001
Enthalten in:
Vaccine, 19/30(2001-07), 4236-44
Format:
Artikel (online)
ID: 439430747